Clinical and Pathological Features of Chinese Patients with Type 2 Diabetes, Biopsy-Proven Diabetic Kidney Disease, and Rapid eGFR Decline

Objective The rate of kidney function decline in patients with diabetic kidney disease (DKD) is known to differ. This study analyzed the clinicopathologic features and related risk factors affecting long-term renal survival in Chinese type 2 diabetic patients with rapid estimated glomerular filtration rate (eGFR) decline. Methods In this retrospective descriptive study, 191 DKD patients were first classified as rapid eGFR decliners and slow eGFR decliners on the basis of the median eGFR slope value (−8.0 mL/min/1.73 m2/year). In total, 96 patients with rapid eGFR decline were included in the analyses and subsequently allocated to end-stage renal disease (ESRD) and non-ESRD groups. Baseline clinicopathological data of rapid eGFR decliners were collected. Cox proportional hazard analysis was performed to calculate the hazard ratios (HRs) for progression to ESRD. Results During a median follow-up of 25 months, 52 (54.2%) rapid eGFR decliners progressed to ESRD. These 52 rapid eGFR decliners had poorer renal function, lower hemoglobin and albumin concentrations, higher total cholesterol and baseline proteinuria levels, and more severe interstitial inflammation than those who did not progress to ESRD. After adjustment for age, gender, baseline eGFR, proteinuria, hemoglobin level, serum albumin concentration, and histopathologic parameters, multivariate Cox proportional hazard analysis revealed that eGFR (HR 0.973, 95% CI 0.956–0.989) and proteinuria (HR 1.125, 95% CI 1.030–1.228) were associated with the increased risk of progression to ESRD. Conclusion Higher proteinuria and lower eGFR were independent risk factors for renal progression in Chinese patients with type 2 diabetes and rapid eGFR decline.

[1]  J. McMurray,et al.  Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. , 2021, The lancet. Diabetes & endocrinology.

[2]  I. Hirsch,et al.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2021, Diabetologia.

[3]  T. Salvatore,et al.  The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy , 2020, Journal of diabetes research.

[4]  T. Nishino,et al.  Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy , 2020, BMJ open diabetes research & care.

[5]  J Zhang,et al.  DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTS. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  Lijun Zhao,et al.  Implications of a Family History of Diabetes and Rapid eGFR Decline in Patients With Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease , 2019, Front. Endocrinol..

[7]  S. Bakker,et al.  Canagliflozin and Renal Outcomes in Diabetic Nephropathy. , 2019, New England Journal of Medicine.

[8]  R. Marfella,et al.  Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study , 2018, Diabetes/metabolism research and reviews.

[9]  Geltrude Mingrone,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2018, Diabetes Care.

[10]  Fang Liu,et al.  Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy , 2018, Renal failure.

[11]  R. Guthrie Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.

[12]  Yichun Hu,et al.  Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD. , 2017, Journal of the American Society of Nephrology : JASN.

[13]  H. Parving,et al.  Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  K. Tuttle,et al.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[15]  J. Skupień,et al.  Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. , 2017, Kidney international.

[16]  Songming Huang,et al.  Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. , 2017, Journal of diabetes and its complications.

[17]  M. Woodward,et al.  Past Decline Versus Current eGFR and Subsequent Mortality Risk. , 2016, Journal of the American Society of Nephrology : JASN.

[18]  R. Wolterbeek,et al.  An autopsy study suggests that diabetic nephropathy is underdiagnosed. , 2016, Kidney international.

[19]  V. Rigalleau,et al.  Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes , 2016, Diabetes Care.

[20]  E. Dassau,et al.  Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes—2015. Diabetes Care 2015;38(Suppl. 1):S41–S48 , 2015, Diabetes Care.

[21]  K. Ohashi,et al.  Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy , 2015, Diabetes/metabolism research and reviews.

[22]  J. Górriz,et al.  The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years , 2015, Journal of clinical medicine.

[23]  A. Krolewski Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes , 2015, Diabetes Care.

[24]  J. Skupień,et al.  The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.

[25]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[26]  T. Nagao,et al.  Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria , 2012, Nephrology.

[27]  Arsh K Jain,et al.  Dipstick proteinuria as a screening strategy to identify rapid renal decline. , 2011, Journal of the American Society of Nephrology : JASN.

[28]  Jai Radhakrishnan,et al.  Pathologic classification of diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[29]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[30]  G. Remuzzi,et al.  How does proteinuria cause progressive renal damage? , 2006, Journal of the American Society of Nephrology : JASN.

[31]  Zhongxin Zhang,et al.  Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.

[32]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.